Religare Enterprises Reports FY26 Results, Q4 Profit Surpasses Full Year

Consolidated revenue for FY26 was ₹8,494 Cr., with Q4 FY26 profit reaching ₹95.65 Cr.

Financial Results and Demerger Approval

Religare Enterprises Limited (REL) announced its financial results for the fiscal year and fourth quarter ending March 31, 2026. The company reported a consolidated profit after tax (PAT) of ₹73.16 Cr. for the full fiscal year FY26, on ₹8,494 Cr. in revenue. The fourth quarter (Q4 FY26) showed a stronger performance, with consolidated PAT at ₹95.65 Cr. on revenues of ₹2,473.30 Cr. Additionally, the boards of REL and Religare Finvest Limited (RFL) approved the demerger of REL's Financial Services Business into RFL.

Why This Matters

The Q4 FY26 results, with profit exceeding the full fiscal year's, suggest strong operations or significant one-time gains in the final quarter. The proposed demerger is a strategic move to create separate, focused businesses for financial services and insurance, potentially unlocking shareholder value.

Background

Religare Enterprises' main businesses are insurance (Care Health Insurance), broking (Religare Broking), and lending (Religare Finvest). In recent years, the Burman family, linked to the Dabur India group, has acquired a significant stake in REL, leading to strategic shifts and board changes. This demerger plan is a key outcome of the new strategic direction aimed at enhancing focus and operational efficiency across its core businesses.

Impact of Demerger

Shareholders may gain exposure to more specialized business units post-demerger, potentially leading to clearer valuation metrics. The company aims for greater operational synergy and management focus within separate insurance and financial services units. Future growth strategies can be tailored and executed independently for each new entity.

Key Risks

Regulatory changes affecting the company's businesses could pose a risk. Compliance with capital adequacy norms set by regulators is critical. Decreasing collateral value or delays in enforcing it upon default can affect lending operations. Managing Non-Performing Assets (NPAs) is a key financial challenge. Risks also include internal or external fraud, operational errors, system malfunctions, and cybersecurity incidents. Volatility in interest rates and market conditions can affect financial performance. Adverse changes in the Indian economy could also impact operations.

Industry Comparison

Peers like Angel One and Motilal Oswal Financial Services, which focus on broking and wealth management, generally reported higher FY26 revenues and PAT than REL's consolidated figures. In insurance, peers like Star Health and ICICI Lombard have significantly larger Gross Written Premiums (GWPs), showing scale advantages. Religare's FY26 PAT of ₹73.16 Cr. is below the typical profitability of leading peers in various segments.

Key Financials

• Consolidated Revenue for FY26: ₹8,494 Cr.
• Consolidated Profit After Tax for FY26: ₹73.16 Cr.
• Care Health Insurance reported Gross Written Premium of ₹11,417 Cr. for FY26.
• Religare Finvest reported a PAT of ₹138.8 Cr. for FY26.

Looking Ahead

The earnings call on May 13, 2026, will offer deeper insights into financial performance and strategic outlook. Investors will monitor progress and regulatory approvals for the proposed demerger of the financial services business. Performance of key subsidiaries, Care Health Insurance and Religare Finvest, will remain a focus for overall company health. The market's reaction to the demerger announcement and FY26 results will be closely watched.